David Langton

Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema

Marco Cicardi, Aleena Banerji, Francisco Bracho et al. · New England Journal of Medicine · 2010 · 540 citations · Full text

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 298 citations

Asthma, Rheumatology, Extension Trial +10

The Melbourne epidemic thunderstorm asthma event 2016: an investigation of environmental triggers, effect on health services, and patient risk factors

Francis Thien, Paul J. Beggs, Danny Csutoros et al. · The Lancet Planetary Health · 2018 · 255 citations · Full text

Therapeutic Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor in Patients with Idiopathic Acquired Alveolar Proteinosis

John F. Seymour, Jeffrey Presneill, Otto D. Schoch et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 246 citations

Mepolizumab effectiveness and identification of super-responders in severe asthma

Erin S. Harvey, David Langton, Constance H. Katelaris et al. · European Respiratory Journal · 2020 · 189 citations · Full text